Pharmacological inhibition of HDAC3 (Fig. S8c) in HS-5 BMSCs via BG45 decreases MM proliferation when compared to MM cells cultured with DMSO-treated HS-5 cells (18% decrease, P value < 0.05) (Fig. S9a). Here, HDAC3 is linked to Miyoshi myopathy.